- Home
- INHD vs CGTX Comparison
INHD vs CGTX Comparison
Compare INHD & CGTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- INHD
- CGTX
- Stock Information
- Founded
- INHD 2019
- CGTX 2007
- Country
- INHD United States
- CGTX United States
- Employees
- INHD N/A
- CGTX N/A
- Industry
- INHD
- CGTX Biotechnology: Pharmaceutical Preparations
- Sector
- INHD
- CGTX Health Care
- Exchange
- INHD Nasdaq
- CGTX Nasdaq
- Market Cap
- INHD 19.8M
- CGTX 23.1M
- IPO Year
- INHD 2023
- CGTX 2021
- Fundamental
- Price
- INHD $1.90
- CGTX $0.33
- Analyst Decision
- INHD
- CGTX Strong Buy
- Analyst Count
- INHD 0
- CGTX 5
- Target Price
- INHD N/A
- CGTX $6.13
- AVG Volume (30 Days)
- INHD 2.4M
- CGTX 942.4K
- Earning Date
- INHD 05-02-2025
- CGTX 05-07-2025
- Dividend Yield
- INHD N/A
- CGTX N/A
- EPS Growth
- INHD N/A
- CGTX N/A
- EPS
- INHD N/A
- CGTX N/A
- Revenue
- INHD $1,559,595.00
- CGTX N/A
- Revenue This Year
- INHD N/A
- CGTX N/A
- Revenue Next Year
- INHD N/A
- CGTX N/A
- P/E Ratio
- INHD N/A
- CGTX N/A
- Revenue Growth
- INHD 287.83
- CGTX N/A
- 52 Week Low
- INHD $2.21
- CGTX $0.31
- 52 Week High
- INHD $19.78
- CGTX $2.95
- Technical
- Relative Strength Index (RSI)
- INHD 30.31
- CGTX 39.84
- Support Level
- INHD $2.21
- CGTX $0.30
- Resistance Level
- INHD $19.78
- CGTX $0.34
- Average True Range (ATR)
- INHD 2.23
- CGTX 0.03
- MACD
- INHD -0.62
- CGTX -0.01
- Stochastic Oscillator
- INHD 3.27
- CGTX 28.31
About INHD Inno Holdings Inc.
Inno Holdings Inc is a building technology company with a mission to transform the construction industry with its proprietary cold-formed steel-framing technology and other innovations. It is a manufacturer of cold-formed-steel members and prefabricated homes. It offers a full range of services required to transform raw materials into precise steel framing products and prefabricated homes. The company sells these finished products either to businesses or directly to customers. The finished products and cold-formed-steel members are used in a variety of building types, including residential, commercial, industrial and infrastructure.
About CGTX Cognition Therapeutics Inc.
Cognition Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of, small-molecule therapeutics targeting age-related degenerative diseases and disorders of the central nervous system and retina. Its product candidate CT1812, is an orally delivered, small-molecule antagonist designed to penetrate the blood-brain barrier and bind selectively to the S2R complex.